ÂÜÀòÂÒÂ×

David Buchsbaum has a diverse work experience spanning several companies and roles. David currently serves as the Chief Financial Officer at ADvantage Therapeutics Inc. since April 2022. Prior to this, David was a Managing Director in Investment Banking at Dawson James Securities, Inc. starting from November 2015. From 2007 to 2015, they worked as a Principal at Boxwood Research. David also held the position of Director of Research at Jewelcor Management/Holtzman Opportunity Fund from 2006 to 2007. Earlier in their career, they were a Senior Vice President at Stanford Group Company from 2003 to 2005 and at Wachovia Securities from 1999 to 2002. David also served as a Vice President at Interstate/Johnson Lane from 1998 to 1999 and as a Partner in Equity Research at Southeast Research Partners from 1994 to 1998. David's first significant role was as the Director of Investor Relations at Claire's Accessories, where they handled shareholder relations and provided financial advice to the Chairman from 1988 to 1993.

David Buchsbaum completed their education at the University of Miami School of Law from 1990 to 1993, earning a JD degree in Law. David also attended the University of Richmond - Robins School of Business from 1982 to 1986, where they obtained a Bachelor of Science degree in Finance and Marketing. There is no information available regarding their education history at the University of Pennsylvania. Additionally, they obtained certifications in Series 7, 63, and 79 from the Financial Industry Regulatory Authority (FINRA).